Trademark Overview
On Wednesday, October 21, 2009, a trademark application was filed for KARGLENI with the United States Patent and Trademark Office. The USPTO has given the KARGLENI trademark a serial number of 79075484. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, January 28, 2010. This trademark is owned by Takeda Pharmaceutical Company Limited. The KARGLENI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders
